drugset / Trial / NCT00712335

The Effects of Montelukast on Smokers With Asthma

NCT00712335

Phase 4 Completed 105 enrolled Inje University
RandomizedParallel-groupSingle-blindDiagnostic

Summary

The purpose of this study is: 1. To compare neutrophilia, eosinophilic inflammatory markers and asthma symptom indices between smokers and non-smokers. 2. To elucidate the mechanism by which cigarette smokers are resistant to corticosteroids.

Timeline

Start
2007-02
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified 250 ug Inhaled
Subject Montelukast Other / unclassified 10 mg Oral
Subject Salmeterol Other / unclassified 50 ug Inhaled